Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Integr Cancer Ther ; 6(1): 42-53, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17351026

ABSTRACT

The effect of various concentrations of Aegle marmelos (AME) on the doxorubicin (DOX)-induced genotoxic effects in mice bone marrow was studied. Treatment of mice with different concentrations of DOX resulted in a dose-dependent elevation in the frequency of micronucleated polychromatic (MPCE) as well as normochromatic (MNCE) erythrocytes in mouse bone marrow. The frequencies of MPCE and MNCE increased with scoring time, and the greatest elevation for MPCE was observed at 48 hours post-DOX treatment, whereas a maximum increase in MNCE was observed at 72 hours post-DOX treatment. This increase in MPCE and MNCE was accompanied by a decline in the polychromatic erythrocytes-normochromatic erythrocytes (PCE/NCE) ratio, which showed a DOX-dose-dependent decline. Treatment of mice with 200, 250, 300, 350, and 400 mg/kg body weight of AME, orally once daily for 5 consecutive days before DOX treatment, significantly reduced the frequency of DOX-induced micronuclei accompanied by a significant elevation in the PCE/NCE ratio at all scoring times. The greatest protection against DOX-induced genotoxicity was observed at 350 mg/kg AME. The protection against DOX-induced genotoxicity by AME may be due to inhibition of free radicals and increased antioxidant status.


Subject(s)
Aegle , Antibiotics, Antineoplastic/toxicity , Bone Marrow/drug effects , Doxorubicin/toxicity , Micronuclei, Chromosome-Defective/drug effects , Animals , DNA Damage/drug effects , Dose-Response Relationship, Drug , Erythrocytes/drug effects , Free Radicals , Male , Mice , Mice, Inbred Strains , Plant Extracts/pharmacology
2.
Toxicol In Vitro ; 2006 Dec 27.
Article in English | MEDLINE | ID: mdl-17270387

ABSTRACT

This article has been removed consistent with Elsevier Policy on Article Withdrawal. Please see http://www.elsevier.com/locate/withdrawalpolicy. The Publisher apologies for any inconvenience this may cause.

SELECTION OF CITATIONS
SEARCH DETAIL
...